ES3058210T3 - Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis - Google Patents
Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosisInfo
- Publication number
- ES3058210T3 ES3058210T3 ES23201936T ES23201936T ES3058210T3 ES 3058210 T3 ES3058210 T3 ES 3058210T3 ES 23201936 T ES23201936 T ES 23201936T ES 23201936 T ES23201936 T ES 23201936T ES 3058210 T3 ES3058210 T3 ES 3058210T3
- Authority
- ES
- Spain
- Prior art keywords
- mir
- hsa
- seq
- mirnas
- alzheimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762521768P | 2017-06-19 | 2017-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3058210T3 true ES3058210T3 (en) | 2026-03-09 |
Family
ID=62952378
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES23201936T Active ES3058210T3 (en) | 2017-06-19 | 2018-06-07 | Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis |
| ES18742857T Active ES2965473T3 (es) | 2017-06-19 | 2018-06-07 | Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18742857T Active ES2965473T3 (es) | 2017-06-19 | 2018-06-07 | Biomarcadores de microARN en suero circulante y métodos para el diagnóstico de la enfermedad de Alzheimer |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US11634775B2 (https=) |
| EP (2) | EP3642366B1 (https=) |
| JP (1) | JP2020524509A (https=) |
| ES (2) | ES3058210T3 (https=) |
| WO (1) | WO2018236589A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020000293A (es) * | 2017-07-12 | 2020-07-22 | Univ Texas Tech System | Microrna-455-3p como un marcador bioperiferico para la enfermedad de alzheimer. |
| CN111073973A (zh) * | 2019-12-10 | 2020-04-28 | 石河子大学 | 一种用于早期诊断2型糖尿病的microRNA序列及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009009457A1 (en) * | 2007-07-06 | 2009-01-15 | University Of Louisville Research Foundation, Inc. | Alzheimer's disease-specific micro-rna microarray and related methods |
| US20120108650A1 (en) * | 2010-10-29 | 2012-05-03 | Emory University | Micro rna markers and methods related thereto |
| BR112013033488B8 (pt) | 2011-06-27 | 2022-11-22 | Eisai R&D Man Co Ltd | Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit |
| CA2838562A1 (en) | 2011-08-08 | 2013-02-14 | Eugenia Wang | Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| WO2013024469A1 (en) * | 2011-08-16 | 2013-02-21 | Rosetta Genomics Ltd. | Methods and compositions for diagnosis of alzheimer's desease |
| JP6930832B2 (ja) | 2013-11-18 | 2021-09-01 | ディアミール, エルエルシーDiamir, Llc | パーキンソン病（ＰＤ）の検出およびモニタリングのための、体液からのｍｉＲＮＡを使用する方法 |
| WO2015179909A1 (en) * | 2014-05-26 | 2015-12-03 | The University Of Melbourne | Mirna biomarkers of alzheimer's disease |
| ES2741591T3 (es) | 2015-03-13 | 2020-02-11 | Univ Hiroshima | Método para ayudar a la detección de la enfermedad de Alzheimer o una discapacidad cognitiva moderada |
| EP3411500B9 (en) * | 2016-02-05 | 2023-10-04 | St. John's University | Circulating serum microrna biomarkers and methods for determining parkinson's disease |
| US11149313B2 (en) * | 2016-03-21 | 2021-10-19 | Diamir, Llc | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases |
-
2018
- 2018-06-07 JP JP2019570475A patent/JP2020524509A/ja active Pending
- 2018-06-07 EP EP18742857.8A patent/EP3642366B1/en active Active
- 2018-06-07 US US16/623,937 patent/US11634775B2/en active Active
- 2018-06-07 ES ES23201936T patent/ES3058210T3/es active Active
- 2018-06-07 WO PCT/US2018/036377 patent/WO2018236589A1/en not_active Ceased
- 2018-06-07 ES ES18742857T patent/ES2965473T3/es active Active
- 2018-06-07 EP EP23201936.4A patent/EP4289970B1/en active Active
-
2023
- 2023-03-13 US US18/182,868 patent/US12398427B2/en active Active
-
2025
- 2025-07-25 US US19/280,334 patent/US20260092326A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US12398427B2 (en) | 2025-08-26 |
| EP4289970B1 (en) | 2025-12-17 |
| EP3642366A1 (en) | 2020-04-29 |
| US20200190588A1 (en) | 2020-06-18 |
| EP3642366C0 (en) | 2023-11-15 |
| EP4289970A3 (en) | 2024-03-13 |
| WO2018236589A1 (en) | 2018-12-27 |
| EP3642366B1 (en) | 2023-11-15 |
| US11634775B2 (en) | 2023-04-25 |
| EP4289970A2 (en) | 2023-12-13 |
| JP2020524509A (ja) | 2020-08-20 |
| EP4289970C0 (en) | 2025-12-17 |
| US20260092326A1 (en) | 2026-04-02 |
| US20240209444A1 (en) | 2024-06-27 |
| ES2965473T3 (es) | 2024-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Soler-Botija et al. | Epigenetic biomarkers in cardiovascular diseases | |
| Dong et al. | Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease | |
| Huang et al. | Recent progress in circular RNAs in human cancers | |
| US20230323442A1 (en) | Circulating serum microrna biomarkers and methods | |
| US20260092326A1 (en) | Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis | |
| CN101974619A (zh) | 测量对多西他赛抗药性或敏感性的方法 | |
| JP2025085828A (ja) | パーキンソン病の進行速度を決定するための循環血清マイクロｒｎａバイオマーカー及び方法 | |
| Xia et al. | Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer | |
| Piscopo et al. | Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia | |
| Cao et al. | Mechanistic study of pre-eclampsia and macrophage-associated molecular networks: bioinformatics insights from multiple datasets | |
| Abolghasemi et al. | Exploration of potential circulating micro-RNA as biomarker for Alzheimer's disease | |
| Ma et al. | Serum miRNA expression and correlation with clinical characteristics in acute kidney injury | |
| Papadopoulos | miRNAs in kidney disease | |
| Michels et al. | Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression | |
| Cameron et al. | Circulating MicroRNAs as biomarkers in coronary heart disease and heart failure | |
| Zöller et al. | Association of recurrent venous thromboembolism and circulating microRNAs |